google-site-verification: googlec7193c3de77668c9.html
Wednesday , October 21 2026

Established cancer drug can reactivate immunotherapy

[
Genetically modified immune cells can offer precious additional time to patients with advanced multiple myeloma. However, these therapies lose their impact as the molecules on cancer cells that immune cells recognize gradually vanish. Researchers at the Technical University of Munich (TUM) have now identified one of the molecular mechanisms behind this process. In an initial study, they succeeded in blocking it using an existing cancer drug.


Source link

Advertisements

See also  Elon Musk reveals why he takes ketamine, denies abusing the drug: ‘I should keep taking it’

Check Also

Reducing nuclear damage improves heart function and survival in mice

[ Graphical abstract. Credit: Circulation Research (2026). DOI: 10.1161/circresaha.125.327744 Reducing damage to the nuclei of …

Africa CDC calls an Ebola crisis summit as Nigeria records its first case

[ A health care worker speaks to a colleague at the Ebola treatment center in …

Brazilian biobank may help personalize cancer prevention in the public health system

[ Credit: Tima Miroshnichenko from Pexels A bank of biological samples from thousands of Brazilians …

Leave a Reply

Available for Amazon Prime